All results
1 results
-
Sarepta 4658-402
**This study will be comprised of 2 parts:** Part 1 (dose escalation) will be conducted to evaluate the safety and tolerability of 2 doses (100…
- Ages
- 4 Years - 13 Years
- Sexes
- Male